Inflammation increases the expression of risk gene in first-episode schizophrenia patients
Can't see this email? View it online
   
  Schizophrenia  
  The latest schizophrenia news from News Medical  
 New evidence of a critical neuroplasticity period in the frontal brain during adolescenceNew evidence of a critical neuroplasticity period in the frontal brain during adolescence
 
In a paper published in Progress in Neurobiology, University of Pittsburgh School of Medicine neuroscientists described compelling new evidence of a critical neuroplasticity period in the frontal brain region during adolescence, a time when major mental illnesses such as depression and schizophrenia emerge and risk-taking behavior peaks.
 
 
 Inflammation increases the expression of risk gene in first-episode schizophrenia patientsInflammation increases the expression of risk gene in first-episode schizophrenia patients
 
Schizophrenia patients have fewer connections between nerve cells. This is believed to be caused by genetic risk variants leading to an excessive elimination of nerve cell connections by the immune cells of the brain.
 
   Researchers unravel how the brain chemical dopamine relates to schizophreniaResearchers unravel how the brain chemical dopamine relates to schizophrenia
 
Researchers at the Lieber Institute for Brain Development (LIBD) believe they have solved a riddle that has challenged scientists for more than 70 years: how the brain chemical dopamine relates to schizophrenia, the often-devastating brain disorder characterized by delusional thinking, hallucinations and other forms of psychosis.
 
 Dangers of recreational/medical cannabis use
 
Dangers of recreational/medical cannabis useResearchers describe the wide range of neurological effects associated with cannabis use.
 
 
 Researchers develop a powerful computational tool for understanding brain health and disease
 
Researchers develop a powerful computational tool for understanding brain health and diseaseA team led by researchers from Brigham and Women's Hospital, a founding member of the Mass General Brigham healthcare system, in close collaboration with investigators at Mass General Hospital and Beth Israel Deaconess Medical Center has developed a powerful computational tool for understanding brain health and disease, providing an enhanced way of characterizing the activity of the brain during sleep.